Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creation of Arteriovenous Ante-brachial Fistula Under Axillary Block Versus Local Anesthesia
NCT02722096Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Mar 2014
- Primary completion
- Jan 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised trial of ropivacaine hydrochloride liposomal suspension injection and Lidocaine Hydrochloride Injection, without epinephrine in chronic kidney disease (CKD) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Rate of early complications related to arteriovenous fistula regardless of type at 6 weeks. Started Mar 2014; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injectionLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02722096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02722096.